Steven Law

1.1k total citations
22 papers, 185 citations indexed

About

Steven Law is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Steven Law has authored 22 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Nephrology and 4 papers in Genetics. Recurrent topics in Steven Law's work include Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Parathyroid Disorders and Treatments (8 papers) and Renal Diseases and Glomerulopathies (3 papers). Steven Law is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Parathyroid Disorders and Treatments (8 papers) and Renal Diseases and Glomerulopathies (3 papers). Steven Law collaborates with scholars based in United Kingdom, United States and Japan. Steven Law's co-authors include Julian D. Gillmore, Andrew Davenport, Marianna Fontana, Ashutosh Wechalekar, Oliver Cohen, Helen J. Lachmann, Philip N. Hawkins, Sriram Ravichandran, Carol Whelan and Janet A. Gilbertson and has published in prestigious journals such as Blood, The American Journal of Medicine and British Journal Of Nutrition.

In The Last Decade

Steven Law

18 papers receiving 181 citations

Peers

Countries citing papers authored by Steven Law

Since Specialization

Citations

This map shows the geographic impact of Steven Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Law more than expected).

Fields of papers citing papers by Steven Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Law. The network helps show where Steven Law may publish in the future.

Co-authorship network of co-authors of Steven Law

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Law. A scholar is included among the top collaborators of Steven Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Law. Steven Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report 2024 ·Journal of Nephrology ·(unknown), Steven Law, Candice Roufosse, (unknown), (unknown)	4
2	When to Suspect and How to Approach a Diagnosis of Amyloidosis 2022 ·The American Journal of Medicine ·Steven Law, Julian D. Gillmore	5
3	Focal Segmental Glomerulosclerosis Complicating Therapy With Inotersen, an Antisense Oligonucleotide Inhibitor: A Case Report 2022 ·American Journal of Kidney Diseases ·Steven Law, Julia T. Arnold, Muhammad U. Rauf, (unknown), Janet A. Gilbertson, Dorota Rowczenio, Jyoti Baharani, Gerald Langman, Marianna Fontana, Julian D. Gillmore	5
4	The effect of changing dialysate bicarbonate concentration on serum bicarbonate, body weight and normalized nitrogen appearance rate 2022 ·Artificial Organs ·Steven Law, Andrew Davenport	0
5	Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis 2022 ·Heart ·Oliver Cohen, (unknown), Aviva Petrie, Sriram Ravichandran, Steven Law, Richa Manwani, Darren Foard, Sajitha Sachchithanantham, Shameem Mahmood, Ana Martinez–Naharro, Marianna Fontana, Carol Whelan, Philip N. Hawkins, Helen J. Lachmann, Julian D. Gillmore, Ashutosh Wechalekar	8
6	The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre 2022 ·Amyloid ·Oliver Cohen, (unknown), Steven Law, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Shameem Mahmood, Sajitha Sachchithanantham, Brendan Wisniowski, Helen J. Lachmann, Carol Whelan, Ana Martinez–Naharro, Marianna Fontana, Philip N. Hawkins, Julian D. Gillmore, Ashutosh Wechalekar	12
7	Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy 2021 ·Heart ·Steven Law, Aviva Petrie, Liza Chacko, Oliver Cohen, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez–Naharro, Helen J. Lachmann, Carol Whelan, David F. Hutt, Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore	20
8	Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis 2021 ·Cardiology Clinics ·Steven Law, Marianna Fontana, Julian D. Gillmore	9
9	Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib 2021 ·Blood Cancer Journal ·Sriram Ravichandran, Oliver Cohen, Steven Law, Darren Foard, Marianna Fontana, Ana Martinez–Naharro, Carol Whelan, Julian D. Gillmore, Helen J. Lachmann, Sajitha Sachchithanantham, Shameem Mahmood, Philip N. Hawkins, Ashutosh Wechalekar	20
10	Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data 2021 ·British Journal of Haematology ·Sriram Ravichandran, Oliver Cohen, Steven Law, Sajitha Sachchithanantham, Shameem Mahmood, Darren Foard, Marianna Fontana, Ana Martinez–Naharro, Carol Whelan, Julian D. Gillmore, Helen J. Lachmann, Philip N. Hawkins, Ashutosh Wechalekar	2
11	Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients 2020 ·British Journal Of Nutrition ·Steven Law, Andrew Davenport	19
12	Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation 2020 ·Kidney International Reports ·(unknown), Steven Law, (unknown), Manuel Rodriguez‐Justo, Kirsty Thomson, Ruth J. Pepper	0
13	Disease Progression in Cardiac Transthyretin Amyloidosis is Indicated by Serial Calculation of National Amyloidosis Centre Transthyretin Amyloidosis Stage 2020 ·ESC Heart Failure ·Steven Law, Aviva Petrie, Liza Chacko, Oliver Cohen, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez–Naharro, Helen J. Lachmann, Carol Whelan, David F. Hutt, Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore	29
14	Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis 2020 ·BMC Nephrology ·Steven Law, Julian D. Gillmore, Janet A. Gilbertson, Paul Bass, Alan D. Salama	5
15	Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis 2020 ·Amyloid ·Oliver Cohen, (unknown), (unknown), Shameem Mahmood, Sajitha Sachchithanantham, Sriram Ravichandran, Steven Law, Helen J. Lachmann, Carol Whelan, Rakesh Popat, Neil Rabin, Kwee Yong, Charalampia Kyriakou, (unknown), (unknown), (unknown), Philip N. Hawkins, Julian D. Gillmore, Ashutosh Wechalekar	13
16	Renal transplant outcomes in amyloidosis 2020 ·Nephrology Dialysis Transplantation ·Steven Law, Oliver Cohen, Helen J. Lachmann, Tamer Rezk, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Philip N. Hawkins, Reza Motallebzadeh, Julian D. Gillmore	18
17	The effect of glucose absorption from peritoneal dialysates on changes in lipid profiles in prevalent peritoneal dialysis patients 2020 ·Peritoneal Dialysis International ·Steven Law, Andrew Davenport	8
18	The Prognostic Importance of the 6-Minute Walk Test in AL Amyloidosis 2020 ·Blood ·Oliver Cohen, (unknown), Sriram Ravichandran, Steven Law, Richa Manwani, Darren Foard, Sajitha Sachchithanantham, Shameem Mahmood, Ana Martinez–Naharro, Marianna Fontana, Carol Whelan, Philip N. Hawkins, Helen J. Lachmann, Julian D. Gillmore, Ashutosh Wechalekar	2
19	The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma 2019 ·Melanoma Research ·(unknown), Steven Law, (unknown), (unknown), (unknown), Peter Dupont, Amna Sheri	5
20	Extensive subcortical white matter, deep grey matter and brainstem oedema in a confused patient: Question 2017 ·Journal of Clinical Neuroscience ·(unknown), Steven Law, Sanjeev Rajakulendran	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact